Paclitaxel pharmaceutical profiling aiming the optimization of a novel lipid nanotherapy
Paclitaxel (PTX) is a cytostatic anticancer drug used extensively in wide types of cancer. Due to its lipophilic nature (Kp(water/n-octanol) = 3.54) PTX needs a vehicle for its administration. The current vehicles used to improve PTX solubilisation and administration, however they present toxicity p...
Main Author: | |
---|---|
Other Authors: | , , , |
Format: | conferenceObject |
Language: | eng |
Published: |
2016
|
Online Access: | http://hdl.handle.net/1822/50322 |
Country: | Portugal |
Oai: | oai:repositorium.sdum.uminho.pt:1822/50322 |